by The tissue and organ transplantation market involves transplantation of tissue and organs from a donor to a recipient. Organ transplantation refers to replacing a failing organ with a healthy organ from another person. Tissue transplantation refers to replacing damaged tissues with healthy tissues as in skin grafts and cornea transplants. Key products in this market include tissues such as bones & tendons, skin & soft tissues, cornea, heart valves, dental tissues, and organs such as kidney, liver, heart, lungs & pancreas. Rapid technological advancements have helped increase the success rate of such transplantation procedures.
The global Tissue And Organ Transplantation Market is estimated to be valued at Us$ 18.05 Bn in 2023 and is expected to exhibit a CAGR Of 7.9% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
One of the key drivers propelling the growth of this market is the technological advancements in the field of transplantations. Advancements such as development of induced pluripotent stem cell transplantation, 3D organ bioprinting, and development of exosomes have made transplantation procedures more successful and are helping increase the supply of donor organs. For instance, bioprinting uses biomaterials, living cells & growth factors to print human organs and tissues for transplantation, which addresses the challenge of donor organ shortage. Similarly, exosomes harvested from donor organs helps reduce immune rejection of transplant organs. Such technological advancements are increasing feasibility and success rate of transplantations and driving the market growth over the forecast period.
Additionally, the shortage of donors is also propelling the tissue and organ transplantation market growth. According to the U.S. Department of Health & Human Services, over 113,000 candidates were on the national transplant waiting list by end of 2020. However, only 39,716 transplants were performed in 2020. This significant gap between demand and supply of donor organs and tissues is propelling growth as it drives research innovation to identify alternative sources and increase rates of organ donation.
Segment Analysis
The Tissue and Organ Transplantation market is dominated by the tissue segment, which accounts for over 60% market share. Tissue transplants involve transplantation of skin, heart valves, bones etc. and are widely performed across the world to treat various medical conditions. Tissue transplants are preferred over organ transplants due to their ease of availability and lesser complexity involved in the procedure.
PEST Analysis
Political: Governments across the world are supporting organ and tissue transplantation through various campaigns and policies. However, shortage of organs remains a key challenge. Some countries also have legal and ethical issues related to organ trade.
Economic: Growing patient population suffering from organ failure or injuries is driving demand. However, high costs associated with transplant procedures and lifelong immuno-suppressant drugs is also a factor.
Social: Social awareness about organ donation is increasing but willingness is still low due to cultural and religious beliefs in many regions. Living organ donations from family members are more prevalent.
Technological: Advancements in immunosuppressant drugs and surgical techniques have significantly increased success rates of transplants. Novel techniques like 3D bioprinting of organs are being researched.
Key Takeaways
The Global Tissue And Organ Transplantation Market Demand is expected to witness high growth over the forecast period supported by rising cases of organ failure, increasing accuracy of transplant procedures and growing awareness.
Regional analysis:
North America dominates the market currently due to presence of advanced healthcare infrastructure and high patient affordability in the region. However, Asia Pacific is poised to witness fastest growth supported by rising medical tourism, infrastructure investments and expanding medical cover.
Key players:
Key players operating in the Tissue and Organ Transplantation market are Probi AB, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc, BioGaia AB, Probiotics International Limited (Protexin), UAS Laboratories LLC. Companies are focusing on developing new drugs to reduce rejection rates as well as technologies like organ bioprinting.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
